COVER STORY TITLE 01
October 2, 2024

The Promise of Gene Therapy in Retinal Disorders

From groundbreaking new therapies to ongoing clinical trials, is gene therapy set to transform the treatment landscape of retinal disorders?…

Elon Musk_2
September 27, 2024

Neuralink’s Blindsight Implant Receives FDA Breakthrough Device Designation

Neuralink (Fremont, United States), Elon Musk’s futuristic neurotechnology company, has reported a step forward in its mission to restore vision…

Discover our fascinating content at issuu

explore